Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)

QR Code

Aspirin for the prevention of cognitive decline in the elderly: Rationale and design of a neuro-vascular imaging study (ENVIS-ion)

Background: This paper describes the rationale and design of the ENVIS-ion Study, which aims to determine whether low-dose aspirin reduces the development of white matter hyper-intense (WMH) lesions and silent brain infarction (SBI). Additional aims include determining whether a) changes in retinal...

Full description

Bibliographic Details
Main Authors:	Reid, Christopher, Storey, E., Wong, T., Woods, R., Tonkin, A., Wang, J., Kam, A., Janke, A., Essex, R., Abhayaratna, W., Budge, M.
Format:	Journal Article
Published:	2012
Online Access:	http://hdl.handle.net/20.500.11937/11371

Similar Items

The Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA study
by: Ward, S., et al.
Published: (2018)

Effect of aspirin on disability-free survival in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Effect of aspirin on all-cause mortality in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

ASPREE-D: Aspirin for the prevention of depression in the elderly
by: Berk, M., et al.
Published: (2016)

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly
by: McNeil, J., et al.
Published: (2018)

Baseline Characteristics of Participants in the ASPREE (Aspirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2019)

Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study
by: McNeil, J., et al.
Published: (2017)

Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study
by: Robman, L., et al.
Published: (2017)

Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)

The aspirin in reducing events in the elderly trial: Statistical analysis plan
by: Wolfe, R., et al.
Published: (2018)

Slowing the progression of age-related hearing loss: Rationale and study design of the ASPIRIN in HEARING, retinal vessels imaging and neurocognition in older generations (ASPREE-HEARING) trial
by: Lowthian, J., et al.
Published: (2016)

Genetic variation in PEAR1, cardiovascular outcomes and effects of aspirin in a healthy elderly population
by: Lewis, J.P., et al.
Published: (2020)

Prevalence of chronic kidney disease in the elderly using the ASPirin in Reducing Events in the Elderly (ASPREE) study cohort
by: Polkinghorne, K., et al.
Published: (2019)

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
by: Grimm, R., et al.
Published: (2013)

Cost-effectiveness of low-dose rivaroxaban and aspirin versus aspirin alone in people with peripheral or carotid artery disease: An Australian healthcare perspective
by: Zomer, E., et al.
Published: (2018)

Quality of Life for 19,114 participants in the ASPREE (ASPirin in Reducing Events in the Elderly) study and their association with sociodemographic and modifiable lifestyle risk factors
by: Stocks, N., et al.
Published: (2018)

Five-Year Decline in Estimated Glomerular Filtration Rate Associated With a Higher Risk of Renal Disease and Atherosclerotic Vascular Disease Clinical Events in Elderly Women
by: Lim, W, et al.
Published: (2013)

Twisted Aspirin Crystals
by: Cui, X., et al.
Published: (2013)

Initial development of Islamic Envy Management Scale (IEMS)
by: Sri , Nurul Milla, et al.
Published: (2015)

Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)

Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke
by: Zhao, Lian, et al.
Published: (2006)

Low Dose Aspirin Usage Among Elderly Australian Residential Aged Care Facility Residents
by: hie, S., et al.
Published: (2009)

Four persons envy-free division: a case study
by: Rahman, Farin, et al.
Published: (2014)

Pussy envy: towards post-colonial agencies of feminine corporeality
by: Hoo, Regina Lei Kim
Published: (2024)

EnviRoof – A Green technology for sustainable stormwater management
by: Noor Suraya, Romali, et al.
Published: (2021)

Targeted LOWering of Central Blood Pressure in patients with hypertension: Baseline recruitment, rationale and design of a randomized controlled trial (The LOW CBP study)
by: Sharman, J., et al.
Published: (2017)

‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk
by: Aldiss, Peter, et al.
Published: (2017)

Dr. Noor Suraya produces EnviRoof for sustainable stormwater management
by: Nur Hartini, Mohd Hatta
Published: (2022)

Simple Synthetic Receptors for Aspirin
by: Nguyen, Thanh Vinh, et al.
Published: (2014)

3D simulation of urban microclimate using ENVI-Met / Norina Omar
by: Omar, Norina
Published: (2018)

Effect of aspirin on cancer incidence and mortality in older adults.
by: McNeil, John J, et al.
Published: (2020)

Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk
by: Halkes, P.H.A., et al.
Published: (2008)

Caregiver Burden is Associated with Cognitive Decline and Physical Disability of Elderly Post-Stroke Patients
by: Othman, Zahiruddin, et al.
Published: (2014)

Validation of the Malay Version of Short Informant Questionnaire on Cognitive Decline in the Elderly (MS-IQCODE)
by: Othman, Zahiruddin, et al.
Published: (2015)

Effects of luxury brand attachment and perceived envy on schadenfreude: does need for uniqueness moderate?
by: Shimul, Anwar Sadat, et al.
Published: (2021)

Dr. Noor Suraya hasilkan EnviRoof bagi pengurusan air ribut mampan
by: Nur Hartini, Mohd Hatta
Published: (2022)

METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: an initiative of the Joint Programme for Neurodegenerative Disease Research
by: Dichgans, Martin, et al.
Published: (2016)

The Rationale behind Competitive Advantage
by: Daruka, Peeyush, et al.
Published: (2012)

An Efficiency Rationale for Expenditure Equalization
by: Petchey, Jeffrey, et al.
Published: (2013)

Randomized factorial trial of esomeprazole and aspirin in Barrett’s oesophagus: the Aspirin and Esomeprazole Chemoprevention in Barrett’s metaplasia Trial (AspECT)
by: Jankowski, Janusz A.Z., et al.
Published: (2018)